Lifevantage Gross Margin 2012-2026 | LFVN
Current and historical gross margin for Lifevantage (LFVN) over the last 10 years. The current gross profit margin for Lifevantage as of March 31, 2026 is %.
| Lifevantage Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $0.20B | $0.15B | 78.06% |
| 2025-12-31 | $0.21B | $0.17B | 78.57% |
| 2025-09-30 | $0.23B | $0.18B | 80.35% |
| 2025-06-30 | $0.23B | $0.18B | 80.70% |
| 2025-03-31 | $0.22B | $0.18B | 80.63% |
| 2024-12-31 | $0.21B | $0.17B | 80.19% |
| 2024-09-30 | $0.20B | $0.16B | 79.59% |
| 2024-06-30 | $0.20B | $0.16B | 79.50% |
| 2024-03-31 | $0.21B | $0.16B | 79.51% |
| 2023-12-31 | $0.21B | $0.17B | 79.62% |
| 2023-09-30 | $0.21B | $0.17B | 79.34% |
| 2023-06-30 | $0.21B | $0.17B | 79.44% |
| 2023-03-31 | $0.21B | $0.17B | 80.09% |
| 2022-12-31 | $0.21B | $0.17B | 80.19% |
| 2022-09-30 | $0.21B | $0.17B | 81.46% |
| 2022-06-30 | $0.21B | $0.17B | 82.04% |
| 2022-03-31 | $0.21B | $0.17B | 81.90% |
| 2021-12-31 | $0.21B | $0.18B | 82.55% |
| 2021-09-30 | $0.22B | $0.18B | 82.65% |
| 2021-06-30 | $0.22B | $0.18B | 82.35% |
| 2021-03-31 | $0.23B | $0.19B | 83.11% |
| 2020-12-31 | $0.23B | $0.19B | 83.41% |
| 2020-09-30 | $0.23B | $0.19B | 83.55% |
| 2020-06-30 | $0.23B | $0.20B | 84.05% |
| 2020-03-31 | $0.23B | $0.19B | 83.41% |
| 2019-12-31 | $0.23B | $0.19B | 83.41% |
| 2019-09-30 | $0.23B | $0.19B | 83.19% |
| 2019-06-30 | $0.23B | $0.19B | 82.74% |
| 2019-03-31 | $0.22B | $0.19B | 83.48% |
| 2018-12-31 | $0.22B | $0.18B | 83.11% |
| 2018-09-30 | $0.21B | $0.17B | 82.86% |
| 2018-06-30 | $0.20B | $0.17B | 82.76% |
| 2018-03-31 | $0.20B | $0.16B | 82.00% |
| 2017-12-31 | $0.19B | $0.16B | 81.96% |
| 2017-09-30 | $0.19B | $0.16B | 82.47% |
| 2017-06-30 | $0.20B | $0.17B | 83.00% |
| 2017-03-31 | $0.20B | $0.17B | 83.17% |
| 2016-12-31 | $0.21B | $0.18B | 83.10% |
| 2016-09-30 | $0.22B | $0.18B | 83.33% |
| 2016-06-30 | $0.21B | $0.17B | 83.50% |
| 2016-03-31 | $0.20B | $0.17B | 83.84% |
| 2015-12-31 | $0.19B | $0.16B | 84.49% |
| 2015-09-30 | $0.18B | $0.16B | 84.70% |
| 2015-06-30 | $0.19B | $0.16B | 85.79% |
| 2015-03-31 | $0.20B | $0.17B | 85.57% |
| 2014-12-31 | $0.21B | $0.18B | 85.78% |
| 2014-09-30 | $0.22B | $0.18B | 85.58% |
| 2014-06-30 | $0.21B | $0.18B | 85.05% |
| 2014-03-31 | $0.21B | $0.18B | 85.24% |
| 2013-12-31 | $0.21B | $0.18B | 85.85% |
| 2013-09-30 | $0.21B | $0.17B | 83.01% |
| 2013-06-30 | $0.21B | $0.17B | 82.69% |
| 2013-03-31 | $0.20B | $0.17B | 82.59% |
| 2012-12-31 | $0.19B | $0.15B | 81.82% |
| 2012-09-30 | $0.16B | $0.14B | 85.53% |
| 2012-06-30 | $0.13B | $0.11B | 85.71% |
| 2012-03-31 | $0.10B | $0.08B | 86.46% |
| 2011-12-31 | $0.07B | $0.06B | 85.71% |
| 2011-09-30 | $0.05B | $0.04B | 84.62% |
| 2011-06-30 | $0.04B | $0.03B | 84.21% |
| 2011-03-31 | $0.03B | $0.02B | 85.19% |
| 2010-12-31 | $0.02B | $0.02B | 85.00% |
| 2010-09-30 | $0.02B | $0.01B | 86.67% |
| 2010-06-30 | $0.01B | $0.01B | 90.91% |
| 2010-03-31 | $0.01B | $0.01B | 77.78% |
| 2009-12-31 | $0.01B | $0.01B | 85.71% |
| 2009-09-30 | $0.01B | $0.00B | 66.67% |
| 2009-06-30 | $0.01B | $0.00B | 60.00% |
| 2009-03-31 | $0.00B | $0.00B | 75.00% |
| 2008-12-31 | $0.00B | $0.00B | 75.00% |
| 2008-09-30 | $0.00B | $0.00B | 100.00% |
| 2008-06-30 | $0.00B | $0.00B | 100.00% |
| 2008-03-31 | $0.00B | $0.00B | 100.00% |
| 2007-12-31 | $0.00B | $0.00B | 100.00% |
| 2007-09-30 | $0.00B | $0.00B | 100.00% |
| 2007-06-30 | $0.01B | $0.01B | 100.00% |
| 2007-03-31 | $0.01B | $0.01B | 100.00% |
| 2006-12-31 | $0.01B | $0.01B | 100.00% |
| 2006-09-30 | $0.01B | $0.01B | 83.33% |
| 2006-06-30 | $0.01B | $0.01B | 71.43% |
| 2006-03-31 | $0.01B | $0.01B | 75.00% |
| 2005-12-31 | $0.01B | $0.01B | 71.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.053B | $0.229B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |